DX Earnings Report: PAMA Cuts Make Little Dent on Q1 Lab Earnings

Email not displaying correctly? View it in your browser.

Jun. 5, 2018

		REVENUES DX Earnings Report: PAMA Cuts Make Little Dent on Q1 Lab Earnings From - National Intelligence Report One quarter into its existence, the new PAMA Medicare Part B fee schedule seems to be having only a marginal impact on at least publicly traded labs. In fact, the recently published… Read More

		NEW PRODUCTS The Dx Pipeline: A Roundup of the Month's Key New Product Launches From - Laboratory Industry Report Agilent, Bio-Techne and Mission Bio were among the producers launching multiple products. Here's a rundown of the key diagnostic product launches from… Read More

		EMERGING TESTS Expanded Carrier Screening IDs Rare Variants in Diverse Populations From - Diagnostic Testing & Emerging Technologies Expanded next-generation sequencing-based carrier screening improves detection of rare and novel pathogenic variants even in… Read More

FALSE CLAIMS
Labs In Court: A roundup of recent cases and enforcement actions involving the diagnostics industry
From - G2 Compliance Advisor
Case: The feds accused a Missouri lab of submitting false claims to Medicare for travel fees in transporting specimens from April 2011 to December 2014. In addition…
Read More

For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com